GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » BIO-key International Inc (NAS:BKYI) » Definitions » Enterprise Value

BKYI (BIO-key International) Enterprise Value : $4.26 Mil (As of Dec. 15, 2024)


View and export this data going back to 1997. Start your Free Trial

What is BIO-key International Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BIO-key International's Enterprise Value is $4.26 Mil. BIO-key International's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was $-5.40 Mil. Therefore, BIO-key International's EV-to-EBIT ratio for today is -0.79.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, BIO-key International's Enterprise Value is $4.26 Mil. BIO-key International's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was $-4.76 Mil. Therefore, BIO-key International's EV-to-EBITDA ratio for today is -0.89.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, BIO-key International's Enterprise Value is $4.26 Mil. BIO-key International's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $7.29 Mil. Therefore, BIO-key International's EV-to-Revenue ratio for today is 0.58.


BIO-key International Enterprise Value Historical Data

The historical data trend for BIO-key International's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-key International Enterprise Value Chart

BIO-key International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.47 10.73 9.87 5.98 2.95

BIO-key International Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.56 2.95 3.43 3.99 3.65

Competitive Comparison of BIO-key International's Enterprise Value

For the Security & Protection Services subindustry, BIO-key International's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIO-key International's Enterprise Value Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, BIO-key International's Enterprise Value distribution charts can be found below:

* The bar in red indicates where BIO-key International's Enterprise Value falls into.



BIO-key International Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

BIO-key International's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

BIO-key International's Enterprise Value for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIO-key International  (NAS:BKYI) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

BIO-key International's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4.258/-5.398
=-0.79

BIO-key International's current Enterprise Value is $4.26 Mil.
BIO-key International's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.40 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

BIO-key International's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=4.258/-4.762
=-0.89

BIO-key International's current Enterprise Value is $4.26 Mil.
BIO-key International's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.76 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

BIO-key International's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4.258/7.292
=0.58

BIO-key International's current Enterprise Value is $4.26 Mil.
BIO-key International's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIO-key International Enterprise Value Related Terms

Thank you for viewing the detailed overview of BIO-key International's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


BIO-key International Business Description

Traded in Other Exchanges
N/A
Address
3349 Highway 138, Building A, Suite E, Wall, NJ, USA, 07719
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
Executives
Michael W Depasquale director, officer: Co-Chief Executive Officer 1285 CORPORATE CENTER DR, STE 175, EAGAN MN 55121
James David Sullivan officer: See Remarks 411 WALNUT ST., PMB #15855, GREEN COVE SPRINGS FL 32043
Cameron E. Williams director 400 N. CASCADES CIRCLE, CANTON GA 30114
Fong Wong Kwok director FLAT C, 27/F., BLOCK 5, GRAND PACIFIC VIEWS, SIU LAM K3 00000
Emmanuel Alia director 15 C SIGNAL HILL ROAD, MADISON CT 06443
Robert J Michel director C/O ASTA FUNDING, INC., 210 SYLVAN AVENUE, ENGLEWOOD CLIFFS NJ 07632
Micron Technology Development Ltd 10 percent owner 5/F., SPA CENTRE, 53-55 LOCKHART ROAD, WANCHAI K3 999077
Yick Fabian Shin director FLAT B, 23/F, TOWER 2B, 19 TONG YON ST.,, THE WINGS IIIA, TSEUNG KWAN O., NEW TERRITORIES K3 00000
Knook Pieter Cornelis director 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Jianhui Yao director SUITES 2601-2, 26/F TOWER 2, NINA TOWER, 8 YEUNG UK RD, TSUEN WAN K3 TWTL 353
Barbara Rivera director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Thomas Gilley director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Iii Thomas Bush, director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Cecilia C Welch officer: Chief Financial Officer PO BOX 588, DUNSTABLE MA 01827
John Schoenherr director C/O ORACLE CORPORATION, 10 VAN DE GRAAFF DRIVE, BURLINGTON MA 01803